DARPP-32 phosphorylation opposes the behavioral effects of nicotine

Biological Psychiatry

Volumn 58, Issue 12, 2005, Pages 981-989

  Zhu, Hongwen ^a   Lee, MoonSook ^a   Guan, Fangxia ^a   Agatsuma, Soh ^a   Scott, Daniel ^a   Fabrizio, Kevin ^a   Fienberg, Allen A ^b,c   Hiroi, Noboru ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c Intra Cellular Therapies Inc   (United States)

Author keywords

Addiction; Dependence; Dopamine; PKA; Plasticity; Striatum

Indexed keywords

CYCLIC AMP PHOSPHODIESTERASE; NICOTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLUID INTAKE; MOUSE; NONHUMAN; PHOSPHORYLATION; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; SMOKING; TASTE; WESTERN BLOTTING;

ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; COTININE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; FEMALE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; PHOSPHORYLATION;

EID: 29044435893     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2005.05.026     Document Type: Article

References (66)

1. W. Adriani, S. Macri, R. Pacifici, G. Laviola Restricted daily access to water and voluntary nicotine oral consumption in mice methodological issues and individual differences Behav Brain Res 134 1-2 2002 21 30
2. J. Archer Tests for emotionality in rats and mice a review Anim Behav 21 2 1973 205 235
3. T. Arinami, H. Ishiguro, E.S. Onaivi Polymorphisms in genes involved in neurotransmission in relation to smoking Eur J Pharmacol 410 2000 215 226
4. A.K. Armitage, D.M. Turner Absorption of nicotine in cigarette and cigar smoke through the oral mucosa Nature 226 1970 1231 1232
5. D.J. Balfour, K.O. Fagerstrom Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders Pharmacol Ther 72 1996 51 81
6. D.J. Balfour, A.E. Wright, M.E. Benwell, C.E. Birrell The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence Behav Brain Res 113 2000 73 83
7. N.L. Benowitz Pharmacology of nicotine addiction and therapeutics Annu Rev Pharmacol Toxicol 36 1996 597 613
8. N.L. Benowitz Nicotine addiction Primary Care 26 3 1999 611 631
9. N.L. Benowitz, H. Porchet, P. Jacob III Nicotine Psychopharmacology Molecular, Cellular and Behavioural Aspects S. Wonnacott M.A.H. Russell I.P. Stolerman 1990 Oxford University Press Oxford 112 157
10. J.A. Bibb, J. Chen, J.R. Taylor, P. Svenningsson, A. Nishi, G.L. Snyder, Z. Yan, Z.K. Sagawa, C.C. Ouimet, A.C. Nairn, E.J. Nestler, P. Greengard Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5 Nature 410 2001 376 380
11. J.A. Bibb, G.L. Snyder, A. Nishi, Z. Yan, L. Meijer, A.A. Fienberg, L.H. Tsai, Y.T. Kwon, J.A. Girault, A.J. Czernik, R.L. Huganir, H.C. Hemmings Jr, A.C. Nairn, P. Greengard Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons Nature 402 1999 669 671
12. J.A. Bouwknecht, T.H. Hijzen, J. van der Gugten, R.A. Maes, R. Hen, B. Olivier Ethanol intake is not elevated in male 5-HT(1B) receptor knockout mice Eur J Pharmacol 403 2000 95 98
13. P. Calabresi, P. Gubellini, D. Centonze, B. Picconi, G. Bernardi, K. Chergui, P. Svenningsson, A.A. Fienberg, P. Greengard Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity J Neurosci 20 2000 8443 8451
14. J.N. Crawley What's Wrong With My Mouse? Behavioral Phenotypes of Transgenic and Knockout Mice 2000 Wiley-Liss New York
15. J.N. Crawley Animal Tests of Anxiety Current Protocols in Neuroscience 2004 John Wiley and Sons New York 8Chapter
16. G. Di Chiara Role of dopamine in the behavioural actions of nicotine related to addiction Eur J Pharmacol 393 2000 295 314
17. A.A. Fienberg, N. Hiroi, P.G. Mermelstein, W. Song, G.L. Snyder, A. Nishi DARPP-32 regulator of the efficacy of dopaminergic neurotransmission Science 281 1998 838 842
18. H. Gaddnas, K. Pietila, T.P. Piepponen, L. Ahtee Enhanced motor activity and brain dopamine turnover in mice during long-term nicotine administration in the drinking water Pharmacol Biochem Behav 70 2001 497 503
19. S.D. Glick, K.E. Visker, I.M. Maisonneuve An oral self-administration model of nicotine preference in rats effects of mecamylamine Psychopharmacology (Berl) 128 1996 426 431
20. P. Greengard The neurobiology of slow synaptic transmission Science 294 2001 1024 1030
21. M. Hamada, H. Higashi, A.C. Nairn, P. Greengard, A. Nishi Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons J Neurochem 90 2004 1094 1103
22. H.C. Hemmings Jr, P. Greengard DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein regional, tissue, and phylogenetic distribution J Neurosci 6 1986 1469 1481
23. C.J. Heyser, A.A. Fienberg, P. Greengard, L.H. Gold DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task Brain Res 867 2000 122 130
24. N. Hiroi, S. Agatsuma Genetic susceptibility to substance dependence Mol Psychiatry 10 2005 336 344
25. N. Hiroi, J.R. Brown, C.N. Haile, H. Ye, M.E. Greenberg, E.J. Nestler FosB mutant mice loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects Proc Natl Acad Sci USA 94 1997 10397 10402
26. N. Hiroi, A.A. Fienberg, C.N. Haile, M. Alburges, G.R. Hanson, P. Greengard, E.J. Nestler Neuronal and behavioural abnormalities in striatal function in DARPP-32-mutant mice Eur J Neurosci 11 1999 1114 1118
27. P. Jacob III, L. Yu, M. Wilson, N.L. Benowitz Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans Biological Mass Spectrometry 20 1991 247 252
28. T. Kita, M. Okamoto, T. Nakashima Nicotine-induced sensitization to ambulatory stimulant effect produced by daily administration into the ventral tegmental area and the nucleus accumbens in rats Life Sci 50 1992 583 590
29. L.C. Klein, M.M. Stine, D.W. Pfaff, D.J. Vandenbergh Laternal nicotine exposure increases nicotine preference in periadolescent male but not female C57B1/6J mice Nicotine Tob Res 5 2003 117 124
30. B.S. Kotlus, D.A. Blizard Measuring gustatory variation in mice a short-term fluid-intake test Physiol Behav 64 1998 37 47
31. S.R. Laviolette, D. van der Kooy The neurobiology of nicotine addiction bridging the gap from molecules to behaviour Nat Rev Neurosci 5 2004 55 65
32. M. Lee, K. Chen, J.C. Shih, N. Hiroi MAO-B knockout mice exhibit deficient habituation of locomotor activity but normal nicotine intake Genes, Brain and Behavior 3 2004 216 227
33. C. Lerman, W. Berrettini Elucidating the role of genetic factors in smoking behavior and nicotine dependence Am J Med Genet 118B 2003 48 54
34. M. Lindskog, P. Svenningsson, L. Pozzi, Y. Kim, A.A. Fienberg, J.A. Bibb Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine Nature 418 2002 774 778
35. M.J. Marks, J.B. Burch, A.C. Collins Genetics of nicotine response in four inbred strains of mice J Pharmacol Exp Ther 226 1983 291 302
36. C.A. McClung, E.J. Nestler Regulation of gene expression and cocaine reward by CREB and DeltaFosB Nat Neurosci 6 2003 1208 1215
37. C.J. Meliska, A. Bartke, G. McGlacken, R.A. Jensen Ethanol, nicotine, amphetamine, and aspartame consumption and preferences in C57BL/6 and DBA/2 mice Pharmacol Biochem Behav 50 1995 619 626
38. C.J. Meliska, A. Bartke, J.L. Vandergriff, R.A. Jensen Ethanol and nicotine consumption and preference in transgenic mice overexpressing the bovine growth hormone gene Pharmacol Biochem Behav 50 1995 563 570
39. P. Murtra, A.M. Sheasby, S.P. Hunt, C. De Felipe Rewarding effects of opiates are absent in mice lacking the receptor for substance P Nature 405 2000 180 183
40. E.J. Nestler Molecular basis of long-term plasticity underlying addiction Nat Rev Neurosci 2 2001 119 128
41. A. Nishi, J.A. Bibb, G.L. Snyder, H. Higashi, A.C. Nairn, P. Greengard Amplification of dopaminergic signaling by a positive feedback loop Proc Natl Acad Sci U S A 97 2000 12840 12845
42. A. Nishi, G.L. Snyder, P. Greengard Bidirectional regulation of DARPP-32 phosphorylation by dopamine J Neurosci 17 1997 8147 8155
43. P.V. Piazza, V. Deroche-Gamonent, F. Rouge-Pont, M. Le Moal Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction J Neurosci 20 2000 4226 4232
44. K. Pietila, I. Laakso, L. Ahtee Chronic oral nicotine administration affects the circadian rhythm of dopamine and 5-hydroxytryptamine metabolism in the striata of mice Naunyn Schmiedebergs Arch Pharmacol 353 1995 110 115
45. S. Pogun, S. Demirgoren, D. Taskiran, L. Kanit, O. Yilmaz, E.O. Koylu Nicotine modulates nitric oxide in rat brain Eur Neuropsychopharmacol 10 2000 463 472
46. L. Pozzi, K. Hakansson, A. Usiello, A. Borgkvist, M. Lindskog, P. Greengard, G. Fisone Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum J Neurochem 86 2003 451 459
47. T.L. Ripley, C.A. Gadd, C. De Felipe, S.P. Hunt, D.N. Stephens Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors Neuropharmacology 43 2002 1258 1268
48. F.O. Risinger, P.A. Freeman, P. Greengard, A.A. Fienberg Motivational effects of ethanol in DARPP-32 knock-out mice J Neurosci 21 2001 340 348
49. S.F. Robinson, M.J. Marks, A.C. Collins Inbred mouse strains vary in oral self-selection of nicotine Psychopharmacology (Berl) 124 1996 332 339
50. J.E. Rose, W.A. Corrigall Nicotine self-administration in animals and humans similarities and differences Psychopharmacology (Berl) 130 1997 28 40
51. P.P. Rowell, H.E. Hurst, C. Marlowe, B.D. Bennett Oral administration of nicotine its uptake and distribution after chronic administration to mice J Pharmacol Methods 9 1983 249 261
52. S. Shiffman, J. Paty, J.D. Kassel, M. Gnys, M. Zetter-Segal Smoking behavior and smoking history of tobacco chippers Exp Clin Psychopharmacol 2 1994 126 142
53. I. Shim, H.T. Kim, Y.H. Kim, B.G. Chun, D.H. Hahm, E.H. Lee Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat Eur J Pharmacol 443 2002 119 124
54. A. Smith, D.C. Roberts Oral self-administration of sweetened nicotine solutions by rats Psychopharmacology (Berl) 120 1995 341 346
55. G.L. Snyder, P.B. Allen, A.A. Fienberg, C.G. Valle, R.L. Huganir, A.C. Nairn, P. Greengard Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo J Neurosci 20 2000 4480 4488
56. G.L. Snyder, J.A. Girault, J.Y. Chen, A.J. Czernik, J.W. Kebabian, J.A. Nathanson, P. Greengard Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus regulation by factors other than dopamine J Neurosci 12 1992 3071 3083
57. J.A. Sparks, J.R. Pauly Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice Psychopharmacology (Berl) 141 1999 145 153
58. I.P. Stolerman, R. Kumar Regulation of drug and water intake in rats dependent on morphine Psychopharmacologia 26 1972 19 28
59. I.P. Stolerman, M. Shoaib The neurobiology of tobacco addiction Trends Pharmacol Sci 12 1991 467 473
60. P. Svenningsson, M. Lindskog, C. Ledent, M. Parmentier, P. Greengard, B.B. Fredholm, G. Fisone Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors Proc Natl Acad Sci U S A 97 2000 1856 1860
61. P. Svenningsson, A. Nishi, G. Fisone, J.A. Girault, A.C. Nairn, P. Greengard DARPP-32 an integrator of neurotransmission Annu Rev Pharmacol Toxicol 44 2004 269 296
62. P. Svenningsson, E.T. Tzavara, R. Carruthers, I. Rachleff, S. Wattler, M. Nehls Diverse psychotomimetics act through a common signaling pathway Science 302 2003 1412 1415
63. R. Walton, E. Johnstone, M. Munafo, M. Neville, S. Griffiths Genetic clues to the molecular basis of tobacco addiction and progress towards personalized therapy Trends Mol Med 7 2001 70 76
64. H. Welzl, K. Battig, S. Berz Acute effects of nicotine injection into the nucleus accumbens on locomotor activity in nicotine-naive and nicotine-tolerant rats Pharmacol Biochem Behav 37 1990 743 746
65. E. Weruaga, B. Balkan, E.O. Koylu, S. Pogun, J.R. Alonso Effects of chronic nicotine administration on nitric oxide synthase expression and activity in rat brain J Neurosci Res 67 2002 689 697
66. V. Zachariou, M. Benoit-Marand, P.B. Allen, P. Ingrassia, A.A. Fienberg, F. Gonon Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or Inhibitor 1 Biol Psychiatry 51 2002 612 620